Carbon3D_Teaser

What if 3D Printing was 1000x Faster?

Just a few months ago, an interesting 3D printing startup emerged from stealth mode called Carbon3D. The Company took the 3D printing community by storm with their claim of a new 3DP technology that was up to 100X faster than current methods. The unveiling of this company's technology was in the form of a TED talk titled "What if 3D printing was 100x faster?". The talk was given by Joseph DeSimone, one of the three founders of Carbon3D, all of whom are materials scientists. Carbon3D's technology is called Continuous Liquid Interface Production or CLIP. During the TED talk, Mr. DeSimone went on to compare traditional 3D printing to his company's CLIP technology which was inspired by that scene in Terminator 2 where the T-1000 emerges from a puddle of fluid.  During the ten-minute talk, a Carbon3D printer "grows" an object from a reservoir of liquid resin in about 6 minutes as seen below: Using traditional 3D [...]

Tesla_Teaser

All About Tesla Energy and the Powerwall Battery

There's no denying that Tesla (NASDAQ:TSLA) has established that certain "cool factor" that companies like Apple (NASDAQ:AAPL) have managed to attain among their consumer/investor/fan base. In an article last year on Protean Electric's in-wheel electric motor, we expounded on just how "cool" the Tesla Model S actually is. This stylish electric all wheel drive with a 270 mile range that goes zero to 60 in 3.1 seconds with nifty features and the highest safety rating in America has generated a great deal of hype. This hype along with the cool factor has managed to excite investors and help propel Tesla's stock price +1100% in the past 5 years. But is that increase merited? While Tesla may have sold around 60,000 units of their flagship Model S seen above in 2014, General Motors, Volkswagen, and Toyota combined sold over 30 million vehicle units in 2014. With GM having a market cap of 56 billion and Tesla's market [...]

BioMark_Diagnostics_Teaser

BioMark Diagnostics Looks At Early Cancer Detection

Cancer detection through blood tests is a cost effective and convenient way to diagnose and treat cancers as opposed to more expensive and cumbersome ways to test for cancer such as biopsies. At an economical price point, cancer blood tests could even be used as preventative measures to catch cancer earlier and increase life expectancy. One Canadian company that's looking to do just that is BioMark Diagnostics     BioMark Diagnostics (CNSX:BUX) was first incorporated less than a year ago on June 19 2014. The below statement by the Company describes their business model: The Company is focused on the research, development and commercialization of its Acetylated Biomarker Assay (ABA) Red Alert technology. The Company’s diagnostic technology is a metabolomics-based diagnostic assay, which allows early cancer detection. The process of cancer detection used by BioMark involves giving a patient the [...]

Evolva_Teaser

Evolva: A Little Known Synthetic Biology Stock

Synthetic biology is a rapidly growing field of interest to investors in multiple industries such as pharmaceuticals and energy. In 2010, an organism was created by Synthetic Genomics which was the first self-replicating species on the planet which had its biological recipe created by a computer. This was the first recorded instance of mankind creating artificial life. The potential of nanotechnology has often been talked about as "self replicating machines that create things for us to use" and that's exactly what synthetic biology is enabling. One little known Swiss company, Evolva, is using genetically modified yeast to create things that are typically found elsewhere in nature.         About Evolva Evolva (SWX:EVE) began trading through a reverse merger with a publicly traded company called Arpida which had lost nearly all of its value after its lead drug candidate did not [...]

Arcadia_Teaser

Investing in Agriculture with Arcadia Biosciences

World food production will continue to be a challenge as population increases while arable land remains the same. While a controversial topic, genetically modified crops or GM crops can be used to exhibit certain positive traits that increase crop yields, decreases costs, and keep the global food supply accessible to a growing population. GM is estimated to have reached a market share in excess of 90% in key crops and countries as of 2013. One company, Arcadia Biosciences, is looking to develop a portfolio of 50 products based on their patented traits and then sell them to the $39.4 billion global seed market. With $16.5 million in cash on hand, Arcadia is looking to raise around $100 million when their IPO debuts this week.         Aracadia Biosciences (NASDAQ:RKDA) has 50 products in development incorporating their traits, 13 that have demonstrated efficacy in field trials, one [...]

Lastest Articles

Intrexon_Teaser

What to do with your Ziopharm (ZIOP) shares

We have published quite a few articles about Intrexon (NYSE:XON) since their IPO in August 2013 because they are a major contender in the area of synthetic biology with a founder who has a proven track record of building and selling multi billion dollar biotech companies. [...]

Carbon3D_Teaser

What if 3D Printing was 1000x Faster?

Just a few months ago, an interesting 3D printing startup emerged from stealth mode called Carbon3D. The Company took the 3D printing community by storm with their claim of a new 3DP technology that was up to 100X faster than current methods. The unveiling of this company's [...]

Moden_Water_Teaser

Portable Desalination Plants from Modern Water

With water being an essential commodity and water shortages being discussed regularly on the news, investors are thinking ahead and looking for ways to invest in a technology that will allow us access to the 97.5% of water on this planet that contains salt. However pure-play [...]